Meyka Pro banner
Shattuck Labs, Inc.

Shattuck Labs, Inc. Fundamental Analysis (NASDAQ: STTK)

STTKNASDAQ
HealthcareBiotechnology
$8.06
$0.16(2.03%)
U.S. Market opens in 16h 59m

Shattuck Labs, Inc. Fundamental Analysis (NASDAQ: STTK)

Shattuck Labs, Inc. (NASDAQ: STTK) shows weak financial fundamentals with a PE ratio of -15.65, profit margin of -52.57%, and ROE of -43.57%. The company generates $0.0B in annual revenue with weak year-over-year growth of -82.52%.

Key Strengths

PEG Ratio-0.15
Current Ratio27.59

Areas of Concern

ROE-43.57%
Operating Margin-55.79%
We analyze STTK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4039.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4039.3/100

We analyze STTK's fundamental strength across five key dimensions:

Efficiency Score

Weak

STTK struggles to generate sufficient returns from assets.

ROA > 10%
-23.82%

Valuation Score

Excellent

STTK trades at attractive valuation levels.

PE < 25
-15.65
PEG Ratio < 2
-0.15

Growth Score

Moderate

STTK shows steady but slowing expansion.

Revenue Growth > 5%
-82.52%
EPS Growth > 10%
53.02%

Financial Health Score

Excellent

STTK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
27.59

Profitability Score

Weak

STTK struggles to sustain strong margins.

ROE > 15%
-4357.06%
Net Margin ≥ 15%
-52.57%
Positive Free Cash Flow
No

Key Financial Metrics

Is STTK Expensive or Cheap?

P/E Ratio

STTK trades at -15.65 times earnings. This suggests potential undervaluation.

-15.65

PEG Ratio

When adjusting for growth, STTK's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values Shattuck Labs, Inc. at 4.91 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.91

EV/EBITDA

Enterprise value stands at -16.14 times EBITDA. This is generally considered low.

-16.14

How Well Does STTK Make Money?

Net Profit Margin

For every $100 in sales, Shattuck Labs, Inc. keeps $-52.57 as profit after all expenses.

-52.57%

Operating Margin

Core operations generate -55.79 in profit for every $100 in revenue, before interest and taxes.

-55.79%

ROE

Management delivers $-43.57 in profit for every $100 of shareholder equity.

-43.57%

ROA

Shattuck Labs, Inc. generates $-23.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

-23.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Shattuck Labs, Inc. generates limited operating cash flow of $-28.57M, signaling weaker underlying cash strength.

$-28.57M

Free Cash Flow

Shattuck Labs, Inc. generates weak or negative free cash flow of $-28.72M, restricting financial flexibility.

$-28.72M

FCF Per Share

Each share generates $-0.32 in free cash annually.

$-0.32

FCF Yield

STTK converts -5.76% of its market value into free cash.

-5.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.91

vs 25 benchmark

P/S Ratio

Price to sales ratio

721.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

27.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.44

vs 25 benchmark

ROA

Return on assets percentage

-0.24

vs 25 benchmark

ROCE

Return on capital employed

-0.26

vs 25 benchmark

How STTK Stacks Against Its Sector Peers

MetricSTTK ValueSector AveragePerformance
P/E Ratio-15.6532.02 Better (Cheaper)
ROE-43.57%569.00% Weak
Net Margin-5256.80%29961.00% Weak
Debt/Equity0.010.53 Strong (Low Leverage)
Current Ratio27.595.67 Strong Liquidity
ROA-23.82%-96.00% (disorted) Weak

STTK outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Shattuck Labs, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-93.96%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

19.96%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

28.88%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ